All Stories

  1. Association between Genetic and Immunological Background of Hepatocellular Carcinoma and Expression of Programmed Cell Death-1
  2. Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study
  3. Lenvatinib as an Initial Treatment in Patients with Intermediate-stage Hepatocellular Carcinoma Beyond up-to-seven Criteria and Child-Pugh A Liver Function: A Proof-of-Concept Study
  4. Current status and perspectives for computer-aided ultrasonic diagnosis of liver lesions using deep learning technology
  5. Liver damage related to immune checkpoint inhibitors
  6. Molecular Scoring of Hepatocellular Carcinoma for Predicting Metastatic Recurrence and Requirements of Systemic Chemotherapy
  7. Cancer immuotherapy for hepatocellular carcinoma
  8. Oncogenic Signal and Tumor Microenvironment in Hepatocellular Carcinoma
  9. Immunological Microenvironment of Hepatocellular Carcinoma and Its Clinical Implication
  10. Monoethanolamine Oleate Sclerotherapy for Polycystic Liver Disease
  11. Reply
  12. Cone-Beam CT Angiography for Hepatocellular Carcinoma: Current Status
  13. Challenges of Clinical Research on Hepatocellular Carcinoma
  14. Reply
  15. 748 Stress Response Links Inflammation and Tumorigenesis in Inflammatory Bowel Disease
  16. Clinical Features of Vascular Disorders Associated with Chronic Hepatitis Virus Infection
  17. Recent Advancements in Comprehensive Genetic Analyses for Human Hepatocellular Carcinoma
  18. Oxidative Stress and Epigenetic Instability in Human Hepatocarcinogenesis
  19. Abstract 5002: Comprehensive DNA methylation profiling of human hepatocellular carcinoma
  20. Genetic and Epigenetic Signatures in Human Hepatocellular Carcinoma:A Systematic Review
  21. 57 Sequential Progression of Aberrant Methylation in Cancer-Related Genes in Various Stages of Human Hepatocarcinogenesis
  22. Extension of abnormal chromosomal region predicts the metastasis of human hepatocellular carcinomas
  23. Vascular endothelial growth factor/ vascular permeability ffactor (VEGF/VPF) in ascites from patients with liver disease